DE1545944A1 - Verfahren zur Herstellung von neuen Sulfonamiden der Pyrimidinreihe - Google Patents

Verfahren zur Herstellung von neuen Sulfonamiden der Pyrimidinreihe

Info

Publication number
DE1545944A1
DE1545944A1 DE1965H0055944 DEH0055944A DE1545944A1 DE 1545944 A1 DE1545944 A1 DE 1545944A1 DE 1965H0055944 DE1965H0055944 DE 1965H0055944 DE H0055944 A DEH0055944 A DE H0055944A DE 1545944 A1 DE1545944 A1 DE 1545944A1
Authority
DE
Germany
Prior art keywords
pyrimidine
group
general formula
phenyl
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE1965H0055944
Other languages
German (de)
English (en)
Inventor
Gruessner Dr-Chem Andre
Lorch Dr-Chem Eckehard
Schnider Dr-Chem Otto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE1545944A1 publication Critical patent/DE1545944A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE1965H0055944 1964-06-19 1965-05-03 Verfahren zur Herstellung von neuen Sulfonamiden der Pyrimidinreihe Pending DE1545944A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH808464 1964-06-19
CH1625264 1964-12-16

Publications (1)

Publication Number Publication Date
DE1545944A1 true DE1545944A1 (de) 1969-12-11

Family

ID=25702776

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1965H0055944 Pending DE1545944A1 (de) 1964-06-19 1965-05-03 Verfahren zur Herstellung von neuen Sulfonamiden der Pyrimidinreihe

Country Status (9)

Country Link
US (1) US3317536A (enExample)
BE (1) BE665446A (enExample)
BR (1) BR6570406D0 (enExample)
DE (1) DE1545944A1 (enExample)
ES (1) ES314360A1 (enExample)
FR (2) FR4678M (enExample)
GB (1) GB1051006A (enExample)
MY (1) MY6800025A (enExample)
NL (1) NL6507576A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510526A1 (de) * 1991-04-25 1992-10-28 F.Hoffmann-La Roche & Co. Aktiengesellschaft Verwendung von Sulfonamiden als Heilmittel und neue Sulfonamide
EP0526708A1 (de) * 1991-06-13 1993-02-10 F. Hoffmann-La Roche Ag Sulfonamide, ihre Herstellung und Verwendung als Heilmittel und Zwischenprodukte

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL23155A (en) * 1964-03-19 1968-10-24 Schering Ag Benzene sulphonamido pyrimidines and pyrimidine intermediate derivatives and a process for their manufacture
DE1670168C3 (de) * 1966-11-29 1975-04-10 Boehringer Mannheim Gmbh, 6800 Mannheim 2-Benzolsulfonamido-4-methyl-5alkyl-pyrimidine und Verfahren zu ihrer Herstellung
IL111959A (en) * 1993-12-17 2000-07-16 Tanabe Seiyaku Co N-(polysubstituted pyrimidin-4-yl) benzenesulfonamide derivatives their preparation and pharmaceutical compositions containing them
US5739333A (en) * 1995-05-16 1998-04-14 Tanabe Seiyaku Co., Ltd. Sulfonamide derivative and process for preparing the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2506351A (en) * 1945-02-14 1950-05-02 American Cyanamid Co 2 (meta-aminobenzenesulfonamido) 5-halopyrimidines and method of preparing same
GB866843A (en) * 1958-12-08 1961-05-03 Ici Ltd Sulphonamidopyrimidines
GB886692A (en) * 1959-03-04 1962-01-10 Ici Ltd Heterocyclic compounds
BE622086A (enExample) * 1961-01-26

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510526A1 (de) * 1991-04-25 1992-10-28 F.Hoffmann-La Roche & Co. Aktiengesellschaft Verwendung von Sulfonamiden als Heilmittel und neue Sulfonamide
EP0526708A1 (de) * 1991-06-13 1993-02-10 F. Hoffmann-La Roche Ag Sulfonamide, ihre Herstellung und Verwendung als Heilmittel und Zwischenprodukte
US5292740A (en) * 1991-06-13 1994-03-08 Hoffmann-La Roche Inc. Sulfonamides

Also Published As

Publication number Publication date
BR6570406D0 (pt) 1973-08-14
ES314360A1 (es) 1966-02-01
FR1443500A (fr) 1966-06-24
BE665446A (enExample) 1965-12-15
MY6800025A (en) 1968-12-31
NL6507576A (enExample) 1965-12-20
FR4678M (enExample) 1967-01-23
GB1051006A (enExample) 1966-12-14
US3317536A (en) 1967-05-02

Similar Documents

Publication Publication Date Title
DE69633332T2 (de) Alpha-substituierte pyrimidin-thioalkylderivate und alkylether als inhibitoren viraler reverser transkriptfase
CH642965A5 (de) Substituierte 5-(2-imidazolin-2-yl)-aminopyrimidine und verfahren zu deren herstellung.
DE2238628B2 (de) Verfahren zur Herstellung von Furanverbindungen
DE2406930A1 (de) Neue heterocyclische verbindungen und verfahren zu ihrer herstellung
DD150609A5 (de) Verfahren zur herstellung von pyrimidin-verbindungen
DE2849537A1 (de) Substituierte 5-(2-imidazolin-2-yl)- aminopyrimidine und verfahren zu deren herstellung
DE69618986T2 (de) Diaminopyrimidine, diese enthaltende pharmazeutische zusammensetzungen und ihre verwendung als antibakterielle mittel
EP0122580A1 (de) Pyrimidinderivate, deren Herstellung und pharmazeutische Präparate
DE1545944A1 (de) Verfahren zur Herstellung von neuen Sulfonamiden der Pyrimidinreihe
DE69719511T2 (de) Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung
DE2443682C2 (de) Neue 2,4-Diamino-5-benzylpyrimidine
DE1545978A1 (de) N-(4-Pyrimidinyl)-anthranilsaeuren und deren Derivate,sowie Verfahren zur Herstellung derselben
DE60224223T2 (de) Neue alkylsulfonamide als endothelinantagonisten
CH638525A5 (de) 3-(tetrazol-5-yl)-1-azaxanthone und verfahren zu ihrer herstellung.
AT257613B (de) Verfahren zur Herstellung von neuen Sulfonamiden der Pyrimidinreihe
DE671787C (de) Verfahren zur Darstellung von Pyrimidinverbindungen
AT222124B (de) Verfahren zur Herstellung von neuen Sulfonamiden der Pyrimidinreihe
AT257616B (de) Verfahren zur Herstellung von neuen Sulfonamide der Pyrimidinreihe
DE2937023A1 (de) Neue substituierte 5-(2-imidazolin-2-yl)-aminopyrimidine und verfahren zu deren herstellung
DE2558150A1 (de) Neue benzylpyrimidine
DE2435934A1 (de) Neue benzylpyrimidine
DE1137441B (de) Verfahren zur Herstellung von 4-Sulfanilamidopyrimidinderivaten
AT237620B (de) Verfahren zur Herstellung von neuen Derivaten des Sulfanilamids
CH605829A5 (en) Sulphonamide-potentiating benzyl-pyrimidines
DE2218220A1 (de) 2.4-Diamino-5-benzylpyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen